Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia

Ann Hematol. 2017 Nov;96(11):1953-1954. doi: 10.1007/s00277-017-3105-8. Epub 2017 Aug 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Dasatinib / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Leukemia, Myeloid, Chronic-Phase / pathology
  • Lymphatic Diseases / chemically induced*
  • Lymphatic Diseases / pathology
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors / therapeutic use
  • Pseudolymphoma / chemically induced*
  • Pseudolymphoma / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Dasatinib